Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma

Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients

(2015) Patrick Roth et al.   EUROPEAN JOURNAL OF CANCER

Analysis of U2 Small Nuclear RNA Fragments in the Bile Differentiates Cholangiocarcinoma from Primary Sclerosing Cholangitis and Other Benign Biliary Disorders

(2014) Alexander Baraniskin et al.   DIGESTIVE DISEASES AND SCIENCES

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

(2013) N Takeshita et al.   BRITISH JOURNAL OF CANCER

Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian Cancer

(2013) J. D. Kuhlmann et al.   CLINICAL CHEMISTRY

Diagnosis and treatment of primary CNS lymphoma

(2013) Agnieszka Korfel et al.   Nature Reviews Neurology

Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma

(2013) Xuhua Mao et al.   NEUROLOGICAL SCIENCES

Alternative Processing of the U2 Small Nuclear RNA Produces a 19–22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum

(2013) Julien Mazières et al.   PLoS One

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma

(2012) C I Jones et al.   BRITISH JOURNAL OF CANCER

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

(2012) Alexander Baraniskin et al.   INTERNATIONAL JOURNAL OF CANCER

MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer?

(2012) Ruth Zarate et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma

(2012) Alexander Baraniskin et al.   JOURNAL OF NEURO-ONCOLOGY

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

(2011) A. Baraniskin et al.   BLOOD

Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system

(2011) Alexander Baraniskin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma

(2011) A. Baraniskin et al.   NEURO-ONCOLOGY

PCA3: From basic molecular science to the clinical lab

(2010) John R. Day et al.   CANCER LETTERS

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

(2009) Annika Juergens et al.   ANNALS OF NEUROLOGY

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline

(2009) Els L. van Persijn van Meerten et al.   EUROPEAN RADIOLOGY

Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data

(2009) J. M. Ruijter et al.   NUCLEIC ACIDS RESEARCH